TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS national Generic Pharmaceuticals Transition 2021_2

Pharmaceutical products
Various medicinal products
UK
Published value
Not published
Submission deadline Not published
Lots published6
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS national Generic Pharmaceuticals Transition 2021_2". Published status: complete. Published value: Value not published. 6 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Jun 2021, 11:32 BST
Last source update4 Jun 2021, 11:32 BST
Recurring procurementNot published
ClassificationPharmaceutical products, Various medicinal products
Delivery area
UK
OCIDocds-h6vhtk-028bae
What is being bought
Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: Allregions: 15/06/2021 to 28/02/2022 (8.5months)Transition CESW: 15/06/2021 to30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5months)NWLN: 15/06/2021 to 31/01/2022 (7.5months)Hospital Only Housekeeping Products:All regions: 15/06/2021 to 31/01/2022 (7.5 months)
What changed
From the official release history
  1. tender value changed
    4 Jun 2021, 11:32 BST
  2. Status changed to complete
    4 Jun 2021, 11:32 BST
  3. Official notice release published
    4 Jun 2021, 11:32 BST
  4. Submission deadline changed to published date
    4 Jun 2021, 11:32 BST
  5. Published value updated to £115,932,694
    19 Jan 2021, 17:50 GMT
  6. Status changed to active
    19 Jan 2021, 17:50 GMT
  7. Official notice release published
    19 Jan 2021, 17:50 GMT
  8. Submission deadline changed to 23 Feb 2021, 13:00 GMT
    19 Jan 2021, 17:50 GMT
  9. Buyer information updated
    19 Jan 2021, 17:50 GMT
Lots and requirements (6)
Published by the contracting authority
  • Lot 1 · #01
    Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #02
    Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #03
    Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #04
    Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #05
    Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #06
    Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions
    cancelled
    Published valueNot published
    NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Jun 2021, 11:32 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Award active
    Not published · Not published
  40. Award active
    Not published · Not published
  41. Award active
    Not published · Not published
  42. Award active
    Not published · Not published
  43. Award active
    Not published · Not published
  44. Award active
    Not published · Not published
  45. Award active
    Not published · Not published
  46. Award active
    Not published · Not published
  47. Award active
    Not published · Not published
  48. Award active
    Not published · Not published
  49. Award active
    Not published · Not published
  50. Award active
    Not published · Not published
  51. Award active
    Not published · Not published
  52. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  53. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  54. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  55. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  56. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  57. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  58. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  59. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  60. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  61. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  62. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  63. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  64. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  65. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  66. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  67. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  68. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  69. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  70. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  71. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  72. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  73. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  74. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  75. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  76. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  77. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  78. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  79. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  80. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  81. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  82. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  83. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  84. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  85. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  86. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  87. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  88. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  89. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  90. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  91. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  92. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  93. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  94. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  95. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  96. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  97. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  98. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  99. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  100. Contract active
    Signed 7 May 2021, 00:00 BST · £1
  101. Contract active
    Signed 7 May 2021, 00:00 BST · £1
Commercial outcome and competition
Awards
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Brown and Burk UK Ltd
Not published · Not published · active
Laboratorio Reig Jofre SA
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Neon Healthcare Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Cipla (EU) Ltd
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Laboratorio Reig Jofre SA
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Neon Healthcare Ltd
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Day Lewis Medical Ltd
Not published · Not published · active
Waverley Pharma Europe Limited
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Lexon UK Ltd
Not published · Not published · active
Aspire Pharma Limited
Not published · Not published · active
Brown and Burk UK Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Cipla (EU) Ltd
Not published · Not published · active
Day Lewis Medical Ltd
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Laboratorio Reig Jofre SA
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Neon Healthcare Ltd
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Day Lewis Medical Ltd
Not published · Not published · active
Waverley Pharma Europe Limited
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Waverley Pharma Europe Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Lexon UK Ltd
Not published · Not published · active
Aspire Pharma Limited
Not published · Not published · active
Brown and Burk UK Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Cipla (EU) Ltd
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Laboratorio Reig Jofre SA
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Neon Healthcare Ltd
Not published · Not published · active
Contracts
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Hospital Only/Housekeeping - DLS/DNE/DNW Regions
£1 · signed 7 May 2021, 00:00 BST · active
Hospital Only/Housekeeping - DLS/DNE/DNW Regions
£1 · signed 7 May 2021, 00:00 BST · active
Hospital Only/Housekeeping - DLS/DNE/DNW Regions
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - LSNE Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - CESW Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Transition Products - NWLN Region
£1 · signed 7 May 2021, 00:00 BST · active
Bid statistics
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
bids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
electronicBids: 40 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
foreignBidsFromEU: 0 (lot 01)
Buyer and organisations in this procedure

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile

  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer
    centralPurchasingBody

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
    lynne.tierney@nhs.net

  • Accord-UK Ltd
    supplier

    Whiddon Valley, Barnstaple, Devon,, UK, EX32 8NS

  • Amarox Limited
    supplier

    Congress House, 14 Lyon Road,, Harrow, Middlesex, UK, HA1 2EN

  • Aspire Pharma Limited
    supplier

    4 Rotherbrook Court, Bedford Road, Petersfield,, Petersfield, Hampshire., UK, GU32 3QG

  • Bristol Laboratories Limited
    supplier

    Bristol House Unit 3 Canalside, Northbridge Road, Berkhamsted, Hertfordshire., UK, HP4 1EG

  • Brown and Burk UK Ltd
    supplier

    6-9 The Square, Stockley Business Park,, Uxbridge, Middlesex, UK, UB11 1FW

  • Cipla (EU) Ltd
    supplier

    6th Floor, 346 Kensington High Street, London, UK, W14 8NS

  • Day Lewis Medical Ltd
    supplier

    2 Peterwood Way,, Croydon ,Surrey, UK, CR0 4UQ

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    6 Riverview Road,, Beverley, East Yorkshire., UK, HU17 0LD

  • Laboratorio Reig Jofre SA
    supplier

    Unit 9a Caddsdown Business Park,, Bideford, Devon, UK, EX39 3DX

  • Lexon UK Ltd
    supplier

    18 Oxleasow Road Moons Moa, East Redditch, UK, B98 0RE

  • Milpharm Ltd/aurobinbdo
    supplier

    Ares Block, Odyssey Business Park, West End Road,, Ruislip, Middlesex, UK, HA4 6QD

  • Morningside Pharmaeuticals
    supplier

    5 Pavillion Way, Castle Business Park,, Loughborough,, UK, LE11 5GW

  • Neon Healthcare Ltd
    supplier

    Mill Studio Business Centre, Crane Mead,, Ware, Herts, UK, SG12 9PY

  • Ranbaxy UK
    supplier

    5th Floor, Hyde Park, Hayes, 3, 11 Millington Road, Hayes, UK, UB3 4AZ

  • Selective Supplies Ltd.
    supplier

    25 Lucastes Lane, Haywards Heath,, West Sussex, UK, RH16 1LE

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk

  • Thornton and Ross Ltd
    supplier

    Linthwaite Laboratories, Manchester Road,, Linthwaite, Huddersfield, UK, HD7 5QH

  • Waverley Pharma Europe Limited
    supplier

    Alexandra House, Office# 234, The Sweepstakes,, Dublin 4, Ireland, UK, D04 C7H2
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published